DRG 813
Medical DRGCoagulation Disorders
What is MS-DRG 813?
MS-DRG 813 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 16 (MDC 16). It maps to 39 ICD-10-CM diagnosis codes. For FY 2026 it carries a relative weight of 1.5253 with a geometric mean length of stay of 3.6 days and an arithmetic mean of 4.7 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
FY 2026 Payment Data
Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).
Linked ICD-10-CM Diagnosis Mappings
- D65
Disseminated intravascular coagulation [defibrination syndrome]
BillableChapter 3 - D66
Hereditary factor VIII deficiency
BillableChapter 3 - D67
Hereditary factor IX deficiency
BillableChapter 3 - D68.00
Von Willebrand disease, unspecified
BillableChapter 3 - D68.01
Von Willebrand disease, type 1
BillableChapter 3 - D68.020
Von Willebrand disease, type 2A
BillableChapter 3 - D68.021
Von Willebrand disease, type 2B
BillableChapter 3 - D68.022
Von Willebrand disease, type 2M
BillableChapter 3 - D68.023
Von Willebrand disease, type 2N
BillableChapter 3 - D68.029
Von Willebrand disease, type 2, unspecified
BillableChapter 3 - D68.03
Von Willebrand disease, type 3
BillableChapter 3 - D68.04
Acquired von Willebrand disease
BillableChapter 3 - D68.09
Other von Willebrand disease
BillableChapter 3 - D68.1
Hereditary factor XI deficiency
BillableChapter 3 - D68.2
Hereditary deficiency of other clotting factors
BillableChapter 3 - D68.311
Acquired hemophilia
BillableChapter 3 - D68.318
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
BillableChapter 3 - D68.32
Hemorrhagic disorder due to extrinsic circulating anticoagulants
BillableChapter 3 - D68.4
Acquired coagulation factor deficiency
BillableChapter 3 - D68.8
Other specified coagulation defects
BillableChapter 3 - D68.9
Coagulation defect, unspecified
BillableChapter 3 - D69.0
Allergic purpura
BillableChapter 3 - D69.1
Qualitative platelet defects
BillableChapter 3 - D69.2
Other nonthrombocytopenic purpura
BillableChapter 3 - D69.3
Immune thrombocytopenic purpura
BillableChapter 3 - D69.41
Evans syndrome
BillableChapter 3 - D69.42
Congenital and hereditary thrombocytopenia purpura
BillableChapter 3 - D69.49
Other primary thrombocytopenia
BillableChapter 3 - D69.51
Posttransfusion purpura
BillableChapter 3 - D69.59
Other secondary thrombocytopenia
BillableChapter 3 - D69.6
Thrombocytopenia, unspecified
BillableChapter 3 - D69.8
Other specified hemorrhagic conditions
BillableChapter 3 - D69.9
Hemorrhagic condition, unspecified
BillableChapter 3 - D75.821
Non-immune heparin-induced thrombocytopenia
BillableChapter 3 - D75.822
Immune-mediated heparin-induced thrombocytopenia
BillableChapter 3 - D75.828
Other heparin-induced thrombocytopenia syndrome
BillableChapter 3 - D75.829
Heparin-induced thrombocytopenia, unspecified
BillableChapter 3 - D75.84
Other platelet-activating anti-PF4 disorders
BillableChapter 3 - R23.3
Spontaneous ecchymoses
BillableChapter 18